BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 37221053)

  • 1. Longitudinal decline in striatal dopamine transporter binding in Parkinson's disease: associations with apathy and anhedonia.
    Costello H; Yamamori Y; Reeves S; Schrag AE; Howard R; Roiser JP
    J Neurol Neurosurg Psychiatry; 2023 Oct; 94(10):863-870. PubMed ID: 37221053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson's disease.
    Costello H; Schrag AE; Howard R; Roiser JP
    medRxiv; 2023 Jun; ():. PubMed ID: 37425947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bidirectional Correlations Between Dopaminergic Function and Motivation in Parkinson's Disease.
    Hinkle JT; Mills KA; Perepezko K; Pontone GM
    J Geriatr Psychiatry Neurol; 2022 May; 35(3):353-362. PubMed ID: 33622073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of striatal dopamine transporter binding with motor and non-motor symptoms in early Parkinson's disease.
    Yang Z; Xie Y; Dou K; Yang L; Xie A
    Clin Transl Sci; 2023 Jun; 16(6):1021-1038. PubMed ID: 36915231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.
    Santangelo G; Vitale C; Picillo M; Cuoco S; Moccia M; Pezzella D; Erro R; Longo K; Vicidomini C; Pellecchia MT; Amboni M; Brunetti A; Salvatore M; Barone P; Pappatà S
    Parkinsonism Relat Disord; 2015 May; 21(5):489-93. PubMed ID: 25753457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apathy Reflects Extra-Striatal Dopaminergic Degeneration in de novo Parkinson's Disease.
    Sampedro F; Martínez-Horta S; Marín-Lahoz J; Pagonabarraga J; Kulisevsky J
    J Parkinsons Dis; 2022; 12(5):1567-1574. PubMed ID: 35491803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's disease.
    Liu R; Umbach DM; Tröster AI; Huang X; Chen H
    Parkinsonism Relat Disord; 2020 Mar; 72():23-30. PubMed ID: 32092703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
    Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS
    Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Neuropsychiatric Symptoms of Parkinson's Disease with Measures of Striatal Dopaminergic Deficiency.
    Bishnoi R; Badir MC; Surya S; Youssef NA
    Curr Alzheimer Res; 2021; 18(6):499-504. PubMed ID: 34455969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current coffee consumption is associated with decreased striatal dopamine transporter availability in Parkinson's disease patients and healthy controls.
    Wang C; Zhou C; Guo T; Jiaerken Y; Yang S; Xu X; Hu L; Huang P; Xu X; Zhang M
    BMC Med; 2023 Jul; 21(1):272. PubMed ID: 37491235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relations of clinical symptoms with dopamine transporter imaging in drug-naïve Parkinson's disease.
    Mito Y; Yabe I; Yaguchi H; Sato C; Takei T; Terae S; Tajima Y
    Clin Neurol Neurosurg; 2020 Sep; 196():105960. PubMed ID: 32593043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Change of DAT SPECT in Parkinson's Disease and Multiple System Atrophy.
    Sakakibara S; Hashimoto R; Katayama T; Kenjyo M; Yokokawa Y; Saito Y; Hirakawa A; Ito M; Nakamura T; Hara K; Hashizume A; Aiba I; Inukai A; Katsuno M
    J Parkinsons Dis; 2020; 10(1):123-130. PubMed ID: 31707374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease.
    Picillo M; Santangelo G; Erro R; Cozzolino A; Amboni M; Vitale C; Barone P; Pellecchia MT
    Parkinsonism Relat Disord; 2017 Apr; 37():106-110. PubMed ID: 28214265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constipation is not associated with dopamine transporter pathology in early drug-naïve patients with Parkinson's disease.
    Pagano G; Yousaf T; Wilson H; Niccolini F; Polychronis S; Chaudhuri KR; Politis M
    Eur J Neurol; 2018 Feb; 25(2):307-312. PubMed ID: 29078029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
    Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
    Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apathy and striatal dopamine defects in non-demented patients with Parkinson's disease.
    Chung SJ; Lee JJ; Ham JH; Lee PH; Sohn YH
    Parkinsonism Relat Disord; 2016 Feb; 23():62-5. PubMed ID: 26717857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus.
    Vriend C; Raijmakers P; Veltman DJ; van Dijk KD; van der Werf YD; Foncke EM; Smit JH; Berendse HW; van den Heuvel OA
    J Neurol Neurosurg Psychiatry; 2014 Feb; 85(2):159-64. PubMed ID: 23813742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine transporter binding in the brain is linked to irritable bowel syndrome in Parkinson's disease.
    Murtomäki K; Joutsa J; Mertsalmi T; Jaakkola E; Mäkinen E; Levo R; Eklund M; Nuuttila S; Pekkonen E; Noponen T; Ihalainen T; Kaasinen V; Scheperjans F
    Brain Behav; 2023 Jul; 13(7):e3097. PubMed ID: 37254594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
    Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease.
    Hinkle JT; Perepezko K; Mills KA; Mari Z; Butala A; Dawson TM; Pantelyat A; Rosenthal LS; Pontone GM
    Parkinsonism Relat Disord; 2018 Oct; 55():8-14. PubMed ID: 30146185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.